Editor's ChoiceFOCIS HIGHLIGHTS

A T-rojan horse strategy for cancer immunotherapy

See allHide authors and affiliations

Science Immunology  07 May 2021:
Vol. 6, Issue 59, eabj3098
DOI: 10.1126/sciimmunol.abj3098

Abstract

CDK4/6 inhibitor–treated breast cancer cells recruit T cells via metabolic stress-induced chemokines.

View Full Text

Stay Connected to Science Immunology